Regulation of mitophagy by the ubiquitin pathway in neurodegenerative diseases

Experimental Biology and Medicine

Volumn 243, Issue 6, 2018, Pages 554-562

  Desai, Shyamal ^a   Juncker, Meredith ^a   Kim, Catherine ^a  

^a LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Mitochondrial; neurodegeneration; pathology; post translational; proteasome; proteolysis

Indexed keywords

ADENOSINE TRIPHOSPHATE; DEUBIQUITINASE; MANGANESE SUPEROXIDE DISMUTASE; UBIQUITIN; CYTOKINE; ISG15 PROTEIN, HUMAN; PROTEASOME;

DEGENERATIVE DISEASE; DNA REPAIR; HUMAN; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOPHAGY; NERVE DEGENERATION; OXIDATIVE STRESS; PATHOGENESIS; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REVIEW; METABOLISM; PATHOPHYSIOLOGY; PROTEINOSIS;

CYTOKINES; HUMANS; MITOCHONDRIAL DEGRADATION; NEURODEGENERATIVE DISEASES; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN AGGREGATION, PATHOLOGICAL; UBIQUITIN; UBIQUITINS;

EID: 85044393711     PISSN: 15353702     EISSN: 15353699     Source Type: Journal    
DOI: 10.1177/1535370217752351     Document Type: Review

References (123)

1. Chan NC, Chan DC., Parkin uses the UPS to ship off dysfunctional mitochondria. Autophagy 2011;7:771–2
2. Jin SM, Youle RJ., PINK1- and Parkin-mediated mitophagy at a glance. J Cell Sci 2012;125:795–9
3. Kubli DA, Gustafsson AB., Mitochondria and mitophagy: the yin and yang of cell death control. Circ Res 2012;111:1208–21
4. Novak I., Mitophagy: a complex mechanism of mitochondrial removal. Antioxid Redox Signal 2012;17:794–802
5. Rub C, Wilkening A, Voos W., Mitochondrial quality control by the Pink1/Parkin system. Cell Tissue Res 2017;367:111–23
6. Whitworth AJ, Pallanck LJ., The PINK1/Parkin pathway: a mitochondrial quality control system? J Bioenerg Biomem 2009;41:499–503
7. Ciechanover A., Early work on the ubiquitin proteasome system, an interview with Aaron Ciechanover. Interview by CDD. Cell Death Differ 2005;12:1167–77
8. Haas AL, Siepmann TJ., Pathways of ubiquitin conjugation. FASEB J 1997;11:1257–68
9. Hochstrasser M., Ubiquitin, proteasomes, and the regulation of intracellular protein degradation. Curr Opin Cell Biol 1995;7:215–23
10. Hochstrasser M., Ubiquitin-dependent protein degradation. Annu Rev Genet 1996;30:405–39
11. Pickart CM., Mechanisms underlying ubiquitination. Annu Rev Biochem 2001;70:503–33
12. Hoeller D, Hecker CM, Dikic I., Ubiquitin and ubiquitin-like proteins in cancer pathogenesis. Nat Rev Cancer 2006;6:776–88
13. Lecker SH, Goldberg AL, Mitch WE., Protein degradation by the ubiquitin-proteasome pathway in normal and disease states. J Am Soc Nephrol 2006;17:1807–19
14. Mani A, Gelmann EP., The ubiquitin-proteasome pathway and its role in cancer. J Clin Oncol 2005;23:4776–89
15. Cenini G, Voos W., Role of mitochondrial protein quality control in oxidative stress-induced neurodegenerative diseases. Curr Alzheimer Res 2016;13:164–73
16. Dupuis L., Mitochondrial quality control in neurodegenerative diseases. Biochimie 2014;100:177–83
17. Huang Q, Figueiredo-Pereira ME., Ubiquitin/proteasome pathway impairment in neurodegeneration: therapeutic implications. Apoptosis 2010;15:1292–311
18. Johri A, Beal MF., Mitochondrial dysfunction in neurodegenerative diseases. J Pharmacol Exp Ther 2012;342:619–30
19. Lin MT, Beal MF., Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature 2006;443:787–95
20. Ross CA, Poirier MA., Protein aggregation and neurodegenerative disease. Nat Med 2004;10:S10
21. Chan NC, Salazar AM, Pham AH, Sweredoski MJ, Kolawa NJ, Graham RL, Hess S, Chan DC., Broad activation of the ubiquitin-proteasome system by Parkin is critical for mitophagy. Hum Mol Genet 2011;20:1726–37
22. Rakovic A, Grunewald A, Kottwitz J, Bruggemann N, Pramstaller PP, Lohmann K, Klein C., Mutations in PINK1 and Parkin impair ubiquitination of Mitofusins in human fibroblasts. PLoS One 2011;6:e16746
23. Ross JM, Olson L, Coppotelli G., Mitochondrial and ubiquitin proteasome system dysfunction in ageing and disease: two sides of the same coin? Int J Mol Sci 2015;16:19458–76
24. Desai SD, Haas AL, Wood LM, Tsai YC, Pestka S, Rubin EH, Saleem A, Nur-E-Kamal A, Liu LF., Elevated expression of ISG15 in tumor cells interferes with the ubiquitin/26S proteasome pathway. Cancer Res 2006;66:921–8
25. Desai SD, Wood LM, Tsai YC, Hsieh TS, Marks JS, Scott GL, Giovanella BC, Liu LF., ISG15 as a novel tumor biomarker for drug sensitivity. Mol Cancer Ther 2008;7:1430–9
26. Wood LM, Sankar S, Reed RE, Haas AL, Liu LF., A novel role for ATM in regulating proteasome-mediated protein degradation through suppression of the ISG15 conjugation pathway. PLoS One 2011;6:e16422
27. Friedman JR, Nunnari J., Mitochondrial form and function. Nature 2014;505:335–43
28. McBride HM, Neuspiel M, Wasiak S., Mitochondria: more than just a powerhouse. Curr Biol 2006;16:R551–60
29. Osellame LD, Blacker TS, Duchen MR., Cellular and molecular mechanisms of mitochondrial function. Best Pract Res Clin Endocrinol Metab 2012;26:711–23
30. Saraste M., Oxidative phosphorylation at the fin de siecle. Science 1999;283:1488–93
31. Fosslien E., Mitochondrial medicine–molecular pathology of defective oxidative phosphorylation. Ann Clin Lab Sci 2001;31:25–67
32. Sabharwal SS, Schumacker PT., Mitochondrial ROS in cancer: initiators, amplifiers or an Achilles' heel? Nat Rev Cancer 2014;14:709–21
33. Sena LA, Chandel NS., Physiological roles of mitochondrial reactive oxygen species. Mol Cell 2012;48:158–67
34. Gao L, Laude K, Cai H., Mitochondrial pathophysiology, reactive oxygen species, and cardiovascular diseases. Vet Clin North Am Small Anim Pract 2008;38:137–55
35. Kirkinezos IG, Moraes CT., Reactive oxygen species and mitochondrial diseases. Semin Cell Dev Biol 2001;12:449–57
36. Rego AC, Oliveira CR., Mitochondrial dysfunction and reactive oxygen species in excitotoxicity and apoptosis: implications for the pathogenesis of neurodegenerative diseases. Neurochem Res 2003;28:1563–74
37. Ni HM, Williams JA, Ding WX., Mitochondrial dynamics and mitochondrial quality control. Redox Biol 2015;4:6–13
38. Baker MJ, Tatsuta T, Langer T., Quality control of mitochondrial proteostasis. Cold Spring Harb Perspect Biol 2011;3:7
39. Twig G, Elorza A, Molina AJ, Mohamed H, Wikstrom JD, Walzer G, Stiles L, Haigh SE, Katz S, Las G, Alroy J, Wu M, Py BF, Yuan J, Deeney JT, Corkey BE, Shirihai OS., Fission and selective fusion govern mitochondrial segregation and elimination by autophagy. EMBO J 2008;27:433–46
40. Soubannier V, Rippstein P, Kaufman BA, Shoubridge EA, McBride HM., Reconstitution of mitochondria derived vesicle formation demonstrates selective enrichment of oxidized cargo. PLoS One 2012;7:e52830
41. Ding WX, Guo F, Ni HM, Bockus A, Manley S, Stolz DB, Eskelinen EL, Jaeschke H, Yin XM., Parkin and mitofusins reciprocally regulate mitophagy and mitochondrial spheroid formation. J Biol Chem 2012;287:42379–88
42. Durcan TM, Fon EA., The three 'P's of mitophagy: PARKIN, PINK1, and post-translational modifications. Genes Dev 2015;29:989–99
43. Glauser L, Sonnay S, Stafa K, Moore DJ., Parkin promotes the ubiquitination and degradation of the mitochondrial fusion factor mitofusin 1. J Neurochem 2011;118:636–45
44. Nguyen TN, Padman BS, Lazarou M., Deciphering the molecular signals of PINK1/Parkin mitophagy. Trends Cell Biol 2016;26:733–44
45. Haas AL., Structural insights into early events in the conjugation of ubiquitin and ubiquitin-like proteins. Mol Cell 2007;27:174–5
46. Li W, Ye Y., Polyubiquitin chains: functions, structures, and mechanisms. Cell Mol Life Sci 2008;65:2397–406
47. Akutsu M, Dikic I, Bremm A., Ubiquitin chain diversity at a glance. J Cell Sci 2016;129:875–80
48. Tenno T, Fujiwara K, Tochio H, Iwai K, Morita EH, Hayashi H, Murata S, Hiroaki H, Sato M, Tanaka K, Shirakawa M., Structural basis for distinct roles of Lys63- and Lys48-linked polyubiquitin chains. Genes Cells 2004;9:865–75
49. Kulathu Y, Komander D., Atypical ubiquitylation – the unexplored world of polyubiquitin beyond Lys48 and Lys63 linkages. Nat Rev Mol Cell Biol 2012;13:508–23
50. Myung J, Kim KB, Crews CM., The ubiquitin-proteasome pathway and proteasome inhibitors. Med Res Rev 2001;21:245–73
51. Ohtake F, Tsuchiya H., The emerging complexity of ubiquitin architecture. J Biochem 2017;161:125–33
52. Sadowski M, Suryadinata R, Tan AR, Roesley SN, Sarcevic B., Protein monoubiquitination and polyubiquitination generate structural diversity to control distinct biological processes. IUBMB Life 2012;64:136–42
53. Saeki Y., Ubiquitin recognition by the proteasome. J Biochem 2017;161:113–24
54. Tanak A., Parkin-mediated selective mitochondrial autophagy, mitophagy: Parkin purges damaged organelles from the vital mitochondrial network. FEBS Lett 2010;584:1386–92
55. Greene AW, Grenier K, Aguileta MA, Muise S, Farazifard R, Haque ME, McBride HM, Park DS, Fon EA., Mitochondrial processing peptidase regulates PINK1 processing, import and Parkin recruitment. EMBO Rep 2012;13:378–85
56. Jin SM, Lazarou M, Wang C, Kane LA, Narendra DP, Youle RJ., Mitochondrial membrane potential regulates PINK1 import and proteolytic destabilization by PARL. J Cell Biol 2010;191:933–42
57. Kazlauskaite A, Martínez-Torres RJ, Wilkie S, Kumar A, Peltier J, Gonzalez A, Johnson C, Zhang J, Hope AG, Peggie M, Trost M, van Aalten DM, Alessi DR, Prescott AR, Knebel A, Walden H, Muqit MM., Binding to serine 65-phosphorylated ubiquitin primes Parkin for optimal PINK1-dependent phosphorylation and activation. EMBO Rep 2015;16:939–54
58. Kane LA, Lazarou M, Fogel AI, Li Y, Yamano K, Sarraf SA, Banerjee S, Youle RJ., PINK1 phosphorylates ubiquitin to activate Parkin E3 ubiquitin ligase activity. J Cell Biol 2014;205:143–53
59. Koyano F, Okatsu K, Kosako H, Tamura Y, Go E, Kimura M, Kimura Y, Tsuchiya H, Yoshihara H, Hirokawa T, Endo T, Fon EA, Trempe JF, Saeki Y, Tanaka K, Matsuda N., Ubiquitin is phosphorylated by PINK1 to activate parkin. Nature 2014;510:162–6
60. Okatsu K, Koyano F, Kimura M, Kosako H, Saeki Y, Tanaka K, Matsuda N., Phosphorylated ubiquitin chain is the genuine Parkin receptor. J Cell Biol 2015;209:111–28
61. Shiba-Fukushima K, Arano T, Matsumoto G, Inoshita T, Yoshida S, Ishihama Y, Ryu KY, Nukina N, Hattori N, Imai Y., Phosphorylation of mitochondrial polyubiquitin by PINK1 promotes Parkin mitochondrial tethering. PLoS Genet 2014;10:e1004861
62. Lazarou M, Sliter DA, Kane LA, Sarraf SA, Wang C, Burman JL, Sideris DP, Fogel AI, Youle RJ., The ubiquitin kinase PINK1 recruits autophagy receptors to induce mitophagy. Nature 2015;524:309–14
63. Swatek KN, Komander D., Ubiquitin modifications. Cell Res 2016;26:399–422
64. Bingol B, Tea JS, Phu L, Reichelt M, Bakalarski CE, Song Q, Foreman O, Kirkpatrick DS, Sheng M., The mitochondrial deubiquitinase USP30 opposes parkin-mediated mitophagy. Nature 2014;510:370–5
65. Cornelissen T, Haddad D, Wauters F, Van Humbeeck C, Mandemakers W, Koentjoro B, Sue C, Gevaert K, D, Strooper B, Verstreken P, Vandenberghe W., The deubiquitinase USP15 antagonizes Parkin-mediated mitochondrial ubiquitination and mitophagy. Hum Mol Genet 2014;23:5227–42
66. Durcan TM, Fon EA., USP8 and PARK2/parkin-mediated mitophagy. Autophagy 2015;11:428–9
67. Durcan TM, Tang MY, Pérusse JR, Dashti EA, Aguileta MA, McLelland GL, Gros P, Shaler TA, Faubert D, Coulombe B, Fon EA., USP8 regulates mitophagy by removing K6-linked ubiquitin conjugates from parkin. EMBO J 2014;33:2473–91
68. Moriya H., Quantitative nature of overexpression experiments. Mol Biol Cell 2015;26:3932–9
69. Rakovic A, Shurkewitsch K, Seibler P, Grünewald A, Zanon A, Hagenah J, Krainc D, Klein C., Phosphatase and tensin homolog (PTEN)-induced putative kinase 1 (PINK1)-dependent ubiquitination of endogenous Parkin attenuates mitophagy: study in human primary fibroblasts and induced pluripotent stem cell-derived neurons. J Biol Chem 2013;288:2223–37
70. Narendra D, Walker JE, Youle R., Mitochondrial quality control mediated by PINK1 and Parkin: links to parkinsonism. Cold Spring Harb Perspect Biol 2012;4:pii a011338
71. Gersch M, Gladkova C, Schubert AF, Michel MA, Maslen S, Komander D., Mechanism and regulation of the Lys6-selective deubiquitinase USP30. Nat Struct Mol Biol 2017;11:920–30
72. Kim W, Bennett EJ, Huttlin EL, Guo A, Li J, Possemato A, Sowa ME, Rad R, Rush J, Comb MJ, Harper JW, Gygi SP., Systematic and quantitative assessment of the ubiquitin-modified proteome. Mol Cell 2011;44:325–40
73. Matsuda N, Tanaka K., The PARK2/Parkin receptor on damaged mitochondria revisited-uncovering the role of phosphorylated ubiquitin chains. Autophagy 2015;11:1700–1
74. Lee MJ, Lee BH, Hanna J, King RW, Finley D., Trimming of ubiquitin chains by proteasome-associated deubiquitinating enzymes. Mol Cell Proteomics 2011;10:R110 003871
75. Wauer T, Swatek KN, Wagstaff JL, Gladkova C, Pruneda JN, Michel MA, Gersch M, Johnson CM, Freund SM, Komander D., Ubiquitin Ser65 phosphorylation affects ubiquitin structure, chain assembly and hydrolysis. EMBO J 2015;34:307–25
76. Imai Y, Kanao T, Sawada T, Kobayashi Y, Moriwaki Y, Ishida Y, Takeda K, Ichijo H, Lu B, Takahashi R., The loss of PGAM5 suppresses the mitochondrial degeneration caused by inactivation of PINK1 in Drosophila. PLoS Genet 2010;6:e1001229
77. Lu W, Karuppagounder SS, Springer DA, Allen MD, Zheng L, Chao B, Zhang Y, Dawson VL, Dawson TM, Lenardo M., Genetic deficiency of the mitochondrial protein PGAM5 causes a Parkinson's-like movement disorder. Nat Commun 2014;5:4930
78. Sekine S, Kanamaru Y, Koike M, Nishihara A, Okada M, Kinoshita H, Kamiyama M, Maruyama J, Uchiyama Y, Ishihara N, Takeda K, Ichijo H., Rhomboid protease PARL mediates the mitochondrial membrane potential loss-induced cleavage of PGAM5. J Biol Chem 2012;287:34635–45
79. Benischke AS, Vasanth S, Miyai T, Katikireddy KR, White T, Chen Y, Halilovic A, Price M, Price F, Jr Liton PB, Jurkunas UV., Activation of mitophagy leads to decline in Mfn2 and loss of mitochondrial mass in Fuchs endothelial corneal dystrophy. Sci Rep 2017;7:6656
80. Richter B, Sliter DA, Herhaus L, Stolz A, Wang C, Beli P, Zaffagnini G, Wild P, Martens S, Wagner SA, Youle RJ, Dikic I., Phosphorylation of OPTN by TBK1 enhances its binding to Ub chains and promotes selective autophagy of damaged mitochondria. Proc Natl Acad Sci U S A 2016;113:4039–44
81. Um JW, Chung KC., Functional modulation of parkin through physical interaction with SUMO-1. J Neurosci Res 2006;84:1543–54
82. Um JW, Han KA, Im E, Oh Y, Lee K, Chung KC., Neddylation positively regulates the ubiquitin E3 ligase activity of parkin. J Neurosci Res 2012;90:1030–42
83. Im E, Yoo L, Hyun M, Shin WH, Chung KC., Covalent ISG15 conjugation positively regulates the ubiquitin E3 ligase activity of parkin. Open Biol 2016;6:pii160193
84. Martinez-Vicente M., Neuronal mitophagy in neurodegenerative diseases. Front Mol Neurosci 2017;10:64
85. Palikaras K, Tavernarakis N., Mitophagy in neurodegeneration and aging. Front Genet. 2012;3:297
86. Whitworth AJ, Pallanck LJ., PINK1/Parkin mitophagy and neurodegeneration-what do we really know in vivo? Curr Opin Genet Dev 2017;44:47–53
87. Ryan BJ, Hoek S, Fon EA, Wade-Martins R., Mitochondrial dysfunction and mitophagy in Parkinson's: from familial to sporadic disease. Trends Biochem Sci 2015;40:200–10
88. Deas E, Wood NW, Plun-Favreau H., Mitophagy and Parkinson's disease: the PINK1-parkin link. Biochim Biophys Acta 2011;1813:623–33
89. Martinez-Vicente M, Talloczy Z, Wong E, Tang G, Koga H, Kaushik S, de Vries R, Arias E, Harris S, Sulzer D, Cuervo AM., Cargo recognition failure is responsible for inefficient autophagy in Huntington's disease. Nat Neurosci 2010;13:567–76
90. Choi BO, Nakhro K, Park HJ, Hyun YS, Lee JH, Kanwal S, Jung SC, Chung KW., A cohort study of MFN2 mutations and phenotypic spectrums in Charcot-Marie-Tooth disease 2A patients. Clin Genet 2015;87:594–8
91. Durcan TM, Kontogiannea M, Thorarinsdottir T, Fallon L, Williams AJ, Djarmati A, Fantaneanu T, Paulson HL, Fon EA., The Machado-Joseph disease-associated mutant form of ataxin-3 regulates parkin ubiquitination and stability. Hum Mol Genet 2011;20:141–54
92. Natale G, Lenzi P, Lazzeri G, Falleni A, Biagioni F, Ryskalin L, Fornai F., Compartment-dependent mitochondrial alterations in experimental ALS, the effects of mitophagy and mitochondriogenesis. Front Cell Neurosci 2015;9:434
93. Wang R, Yang B, Zhang D., Activation of interferon signaling pathways in spinal cord astrocytes from an ALS mouse model. Glia 2011;59:946–58
94. Palomo GM, Manfredi G., Exploring new pathways of neurodegeneration in ALS: the role of mitochondria quality control. Brain Res 2015;1607:36–46
95. Pickles S, Destroismaisons L, Peyrard SL, Cadot S, Rouleau GA, Brown RH, Jr Julien JP, Arbour N, Vande Velde C., Mitochondrial damage revealed by immunoselection for ALS-linked misfolded SOD1. Hum Mol Genet 2013;22:3947–59
96. Jiang Z, Wang W, Perry G, Zhu X, Wang X., Mitochondrial dynamic abnormalities in amyotrophic lateral sclerosis. Transl Neurodegener 2015;4:14
97. Komatsu M, Waguri S, Chiba T, Murata S, Iwata J, Tanida I, Ueno T, Koike M, Uchiyama Y, Kominami E, Tanaka K., Loss of autophagy in the central nervous system causes neurodegeneration in mice. Nature 2006;441:880–4
98. Mendonca DM, Chimelli L, Martinez AM., Expression of ubiquitin and proteasome in motorneurons and astrocytes of spinal cords from patients with amyotrophic lateral sclerosis. Neurosci Lett 2006;404:315–9
99. Luo G, Yi J, Ma C, Xiao Y, Yi F, Yu T, Zhou J., Defective mitochondrial dynamics is an early event in skeletal muscle of an amyotrophic lateral sclerosis mouse model. PLoS One 2013;8:e82112
100. Ruffoli R, Bartalucci A, Frati A, Fornai F., Ultrastructural studies of ALS mitochondria connect altered function and permeability with defects of mitophagy and mitochondriogenesis. Front Cell Neurosci 2015;9:341
101. Ambrose M, Goldstine JV, Gatti RA., Intrinsic mitochondrial dysfunction in ATM-deficient lymphoblastoid cells. Hum Mol Genet 2007;16:2154–64
102. Valentin-Vega YA, Maclean KH, Tait-Mulder J, Milasta S, Steeves M, Dorsey FC, Cleveland JL, Green DR, Kastan MB., Mitochondrial dysfunction in ataxia-telangiectasia. Blood 2012;119:1490–500
103. Desai SD, Reed RE, Babu S, Lorio EA., ISG15 Deregulates autophagy in genotoxin-treated ataxia telangiectasia cells. J Biol Chem 2013;288:2388–402
104. Bogunovic D, Boisson-Dupuis S, Casanova JL., ISG15: leading a double life as a secreted molecule. Exp Mol Med 2013;45:e18
105. D'Cunha J, Ramanujam S, Wagner RJ, Witt PL, Knight E, Jr Borden EC., In vitro and in vivo secretion of human ISG15, an IFN-induced immunomodulatory cytokine. J Immunol 1996;157:4100–8
106. Desai SD., ISG15: a double edged sword in cancer. Oncoimmunology 2015;4:e1052935
107. Dao CT, Zhang DE., ISG15: a ubiquitin-like enigma. Front Biosci 2005;10:2701–22
108. Haas AL., ISG15-dependent Regulation. In: Mayer RJ, Ciechnover A, Rechsteiner M, (eds) Protein degradation. Weinheim, Germany: Wiley-VCH Verlag GmbH & Co., 2006, pp.103–31
109. Osiak A, Utermohlen O, Niendorf S, Horak I, Knobeloch KP., ISG15, an interferon-stimulated ubiquitin-like protein, is not essential for STAT1 signaling and responses against vesicular stomatitis and lymphocytic choriomeningitis virus. Mol Cell Biol 2005;25:6338–45
110. Burks J, Reed RE, Desai SD., ISGylation governs the oncogenic function of Ki-Ras in breast cancer. Oncogene 2014;33:794–803
111. Dastur A, Beaudenon S, Kelley M, Krug RM, Huibregtse JM., Herc5, an interferon-induced HECT E3 enzyme, is required for conjugation of ISG15 in human cells. J Biol Chem 2006;281:4334–8
112. Narasimhan J, Potter JL, Haas AL., Conjugation of the 15-kDa interferon-induced ubiquitin homolog is distinct from that of ubiquitin. J Biol Chem 1996;271:324–30
113. Bektas N, Noetzel E, Veeck J, Press MF, Kristiansen G, Naami A, Hartmann A, Dimmler A, Beckmann MW, Knüchel R, Fasching PA, Dahl E., The ubiquitin-like molecule interferon-stimulated gene 15 (ISG15) is a potential prognostic marker in human breast cancer. Breast Cancer Res 2008;10:R58
114. Chen RH, Du Y, Han P, Wang HB, Liang FY, Feng GK, Zhou AJ, Cai MY, Zhong Q, Zeng MS, Huang XM., ISG15 predicts poor prognosis and promotes cancer stem cell phenotype in nasopharyngeal carcinoma. Oncotarget 2016;7:16910–22
115. Zuo C, Sheng X, Ma M, Xia M, Ouyang L., ISG15 in the tumorigenesis and treatment of cancer: an emerging role in malignancies of the digestive system. Oncotarget 2016;7:74393–409
116. Bogunovic D, Byun M, Durfee LA, Abhyankar A, Sanal O, Mansouri D, Salem S, Radovanovic I, Grant AV, Adimi P, Mansouri N, Okada S, Bryant VL, Kong XF, Kreins A, Velez MM, Boisson B, Khalilzadeh S, Ozcelik U, Darazam IA, Schoggins JW, Rice CM, Al-Muhsen S, Behr M, Vogt G, Puel A, Bustamante J, Gros P, Huibregtse JM, Abel L, Boisson-Dupuis S, Casanova JL., Mycobacterial disease and impaired IFN-gamma immunity in humans with inherited ISG15 deficiency. Science 2012;337:1684–8
117. Dai J, Pan W, Wang P., ISG15 facilitates cellular antiviral response to dengue and west nile virus infection in vitro. Virol J 2011;8:468
118. Lenschow DJ., Antiviral Properties of ISG15. Viruses 2010;2:2154–68
119. Malakhova OA, Zhang DE., ISG15 inhibits Nedd4 ubiquitin E3 activity and enhances the innate antiviral response. J Biol Chem 2008;283:8783–7
120. Takeuchi T, Yokosawa H., ISG15 modification of Ubc13 suppresses its ubiquitin-conjugating activity. Biochem Biophys Res Commun 2005;336:9–13
121. Fan JB, Arimoto K, Motamedchaboki K, Yan M, Wolf DA, Zhang DE., Identification and characterization of a novel ISG15-ubiquitin mixed chain and its role in regulating protein homeostasis. Sci Rep 2015;5:12704
122. Kim CD, Reed RE, Juncker MA, Fang Z, Desai SD., Evidence for the deregulation of protein turnover pathways in Atm-deficient mouse cerebellum: an organotypic study. J Neuropathol Exp Neurol 2017;76:578–84
123. Wang RG, Kaul M, Zhang DX., Interferon-stimulated gene 15 as a general marker for acute and chronic neuronal injuries. Sheng Li Xue Bao 2012;64:577–83